WYMZYA Fe could possibly be initiated no before than day 28 postpartum during the nonlactating mother because of the elevated risk for thromboembolism. In the event the tablets are administered within the postpartum interval, the elevated threat of thromboembolic disease linked to the postpartum period of time has to be regarded (see CONTRAINDICATI